Monopar Therapeutics
Price & Volume
Stats
See moreOpen | $41 |
Previous Close | $40.25 |
Day Range | $35.59-$41.45 |
52W Range | $1.72-$54.30 |
Market Cap | $245.6M |
Shares Short | 30,636 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.98 |
News
See moreYahoo Finance • 21 days ago
Why Monopar Therapeutics Inc (MNPR) Is Skyrocketing So Far In 2025
Yahoo Finance • last year
Monopar Therapeutics Reports Third Quarter 2023 Financial Results and Recent Developments
Yahoo Finance • last year
Monopar Presents Data Showing Tumor Reduction Benefit of Camsirubicin from Ongoing Phase 1b at the 2023 Connective Tissue Oncology Society (CTOS) Annual Meeting
Yahoo Finance • last year
Monopar to Participate in the Roth MKM 2023 Healthcare Opportunities Conference
About
CEO | Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc |
CFO | Mr. Karthik Radhakrishnan CFA |
Address | 1000 Skokie Boulevard, Wilmette, IL, United States, 60091 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 9 |
